AEON Biopharma Inc (AMEX:AEON) has a beta value of 0.19 and has seen 46.2 million shares traded in the recent trading session. The company, currently valued at $7.80M, closed the recent trade at $0.19 per share which meant it lost -$0.38 on the day or -66.84% during that session. The AEON stock price is -8936.84% off its 52-week high price of $17.17 and -163.16% below the 52-week low of $0.50. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.18 million shares traded. The 3-month trading volume is 201.48K shares.
The consensus among analysts is that AEON Biopharma Inc (AEON) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.18.
AEON Biopharma Inc (AMEX:AEON) trade information
Sporting -66.84% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the AEON stock price touched $0.19 or saw a rise of 67.92%. Year-to-date, AEON Biopharma Inc shares have moved -65.06%, while the 5-day performance has seen it change -68.02%. Over the past 30 days, the shares of AEON Biopharma Inc (AMEX:AEON) have changed -71.84%. Short interest in the company has seen 0.16 million shares shorted with days to cover at 1.6.
AEON Biopharma Inc (AEON) estimates and forecasts
The company’s shares have lost -81.50% over the past 6 months, compared to 16.90% for the industry. Revenue growth from the last financial year stood is estimated to be 0.00%.
AEON Dividends
AEON Biopharma Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
AEON Biopharma Inc (AMEX:AEON)’s Major holders
Insiders own 36.23% of the company shares, while shares held by institutions stand at 33.14% with a share float percentage of 51.98%. Investors are also buoyed by the number of investors in a company, with AEON Biopharma Inc having a total of 34.0 institutions that hold shares in the company.